Treatment of metastatic disease

Details for Australian Patent Application No. 2006202023 (hide)

International Classifications

Event Publications

1 June 2006 Complete Application Filed

15 June 2006 Application Open to Public Inspection

Published as AU-B-2006202023

27 July 2006 Corrigenda

Applications OPI - Name Index Under the names Glaxo Group Limited, The University of North Carolina at Chapel Hill, and Purdue Research Foundation, Application No. 2006202023, under INID (22) correct the date to read 12.05.06

2 October 2008 Application Accepted

Published as AU-B-2006202023

29 January 2009 Standard Patent Sealed

22 October 2009 Assignment Registered

Glaxo Group Limited; Purdue Research Foundation; University of North Carolina at Chapel Hill The patent has been assigned to Purdue Research Foundation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.